Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04444661
Other study ID # FrOST-FU
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 10, 2020
Est. completion date December 31, 2020

Study information

Verified date April 2021
Source University of Erlangen-Nürnberg Medical School
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Osteosarcopenia designates the simultaneous presence of sarcopenia and osteopenia; both chronic conditions of advanced age. Dynamic-resistance exercise (DRT) might be the most powerful agent to fight osteosarcopenia. Indeed, in the present FrOST study, we clearly determine the positive effect of slightly adapted 18 month high-intensity (HIT)-DRT on bone mineral density (BMD), sarcopenia and other health related parameters in osteosarcopenic men. However, after a short training break, COVID-19 induced lock down prevented a re-start of the HIT resistance exercise training in the FrOST cohort. The aim of the present observational study is thus to determine the effects of 6 months of deconditioning on health related parameters under special regard of osteosarcopenia in this cohort of older men with osteosarcopenia.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date December 31, 2020
Est. primary completion date November 11, 2020
Accepts healthy volunteers No
Gender Male
Age group 74 Years to 95 Years
Eligibility Inclusion Criteria: - participants of the FrOST study (NCT03453463) Exclusion Criteria: - medication and diseases with potential impact on study outcomes during the last 26 weeks.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Institute of Medical Physics, Friedrich Alexander University Erlangen-Nürnberg Erlangen Bavaria

Sponsors (2)

Lead Sponsor Collaborator
University of Erlangen-Nürnberg Medical School Friedrich-Alexander-Universität Erlangen-Nürnberg

Country where clinical trial is conducted

Germany, 

References & Publications (2)

Kemmler W, Kohl M, Fröhlich M, Jakob F, Engelke K, von Stengel S, Schoene D. Effects of High-Intensity Resistance Training on Osteopenia and Sarcopenia Parameters in Older Men with Osteosarcopenia-One-Year Results of the Randomized Controlled Franconian Osteopenia and Sarcopenia Trial (FrOST). J Bone Miner Res. 2020 Sep;35(9):1634-1644. doi: 10.1002/jbmr.4027. Epub 2020 Apr 28. — View Citation

Lichtenberg T, von Stengel S, Sieber C, Kemmler W. The Favorable Effects of a High-Intensity Resistance Training on Sarcopenia in Older Community-Dwelling Men with Osteosarcopenia: The Randomized Controlled FrOST Study. Clin Interv Aging. 2019 Dec 16;14:2173-2186. doi: 10.2147/CIA.S225618. eCollection 2019. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary SMI Skeletal muscle mass index (appendicular skeletal muscle mass / body height; kg/m2) as determined by Dual Energy x-Ray Absorptiometry Change from Baseline to 26 weeks
Secondary BMD-LS Bone Mineral Density at the Lumbar Spine as determined by Dual Energy x-Ray Absorptiometry Change from Baseline to 26 weeks
Secondary BMD-hip Bone Mineral Density at the total hip as determined by Dual Energy x-Ray Absorptiometry Change from Baseline to 26 weeks
Secondary Sarcopenia-Z-Score Z-Score of parameters constituting the metabolic syndrome (i.e. SMI, hand-grip strength, gait velocity) Change from Baseline to 26 weeks
Secondary Fat infiltration thigh muscles Intramuscular adipose tissue at the mid thigh as determined by Magnetic Resonance Imaging Change from Baseline to 26 weeks
Secondary Fat infiltration para-vertebral muscles Intramuscular adipose tissue at the mid thigh as determined by Magnetic Resonance Imaging Change from Baseline to 26 weeks
Secondary Maximum hip-/leg extensor strength Maximum hip-/leg extensor strength as determined by an isokinetic leg press Change from Baseline to 26 weeks
Secondary Metabolic Syndrome Z-Score Metabolic Syndrome Z-Score based on the definition of the International Diabetes Federation including waist circumference, resting glucose, HDL-cholesterol, triglyzerides, mean arterial blood pressure) Change from Baseline to 26 weeks
Secondary Self rated physical performance Late-Life Function and Disability Index of McAuley et al. Change from Baseline to 26 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06287502 - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis N/A
Completed NCT03822078 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women Phase 1
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Completed NCT04736693 - Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Not yet recruiting NCT06431867 - Primary Care Management of Osteoporosis in Older Women
Completed NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study
Recruiting NCT02635022 - Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Active, not recruiting NCT02617303 - Prevention of Falls and Its Consequences in Elderly People N/A
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Completed NCT03420716 - Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women N/A
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Completed NCT02559648 - Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis Phase 2
Unknown status NCT01913834 - Nasally and sc Administered Teriparatide in Healthy Volunteers Phase 1
Completed NCT02003716 - DeFRA Questionnaire as an Anamnestic Form N/A
Not yet recruiting NCT01854086 - Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday N/A
Completed NCT01401556 - C-STOP Fracture Trial N/A
Completed NCT01694784 - Understanding and Discouraging Overuse of Potentially Harmful Screening Tests N/A